Skip to main content
. 2014 Jan 22;4:3811. doi: 10.1038/srep03811

Table 1. Effect of different protease inhibitors on the proteolytic activity of HIB supernatant.

Inhibitors Concentration (μM) Relative % remaining protease activity of the HIB supernatant
ABESF 5000 7.99 (±1.36)
EDTA 500 54.76 (±4.52)
EDTA 5000 32.64 (±2.86)
E-64 50 117.98 (±20.09)
Bestatin 500 64.11 (±5.67)
Pepstatin A 75 88.74 (±12.18)